![]() |
|
|
Vol. 28, Issue 3, 279-285, March 2000
Division of Pharmaceutics and Biopharmaceutics, Faculty of
Pharmaceutical Sciences (S.K., G.R.T., and K.W.R.) and B.C.
Research Institute of Children's and Women's Health, Department of
Obstetrics and Gynecology, Faculty of Medicine (D.W.R.), The University
of British Columbia, Vancouver, British Columbia, Canada
The objective of this study was to examine the interrelationships
between maternal and fetal plasma drug protein binding, umbilical blood
flow (Qum), gestational age (GA), and maternal-fetal diphenhydramine (DPHM) clearances in chronically instrumented pregnant
sheep. Maternal and fetal DPHM placental (CLmf and
CLfm, respectively) and nonplacental (CLmo and
CLfo, respectively) clearances and steady-state plasma
protein binding were determined in 18 pregnant sheep at 124 to 140 days' gestation (term, ~145 days). The data demonstrated a highly
significant fall of ~66% in CLfm and a decreasing trend
in CLfo (~47%) over the GA range studied. However, no
such relationships existed between GA and CLmf or CLmo. Concomitant with this was a decrease in fetal DPHM
plasma unbound fraction with GA, with no such change being evident in the mother. Both CLmo and CLfo were related to
the respective DPHM plasma unbound fraction. A strong relationship
also existed between fetal plasma unbound fraction and
CLfm. Thus, the decrease in fetal unbound fraction of DPHM
during gestation could contribute to the fall in CLfm, and
possibly CLfo. However, over the GA range studied, fetal
DPHM free fraction decreased by ~47%, whereas CLfm fell
by ~66%. Because fetal unbound fraction and CLfm are
linearly related, the GA-associated fall in unbound fraction appears to be insufficient to account for the entire decline in CLfm.
In separate studies in pregnant sheep, we observed a ~40% fall in weight-normalized Qum between 125 and 137 days' gestation.
Because CLfm for DPHM is similar to that of flow-limited
compounds (e.g., ethanol, antipyrine), this decrease in Qum
may also contribute to the GA-related fall in
CLfm.
This article has been cited by other articles:
![]() |
S. C.S. Au-Yeung, K. W. Riggs, N. Gruber, and D. W. Rurak The Use of Microdialysis for the Study of Drug Kinetics: Central Nervous System Pharmacokinetics of Diphenhydramine in Fetal, Newborn, and Adult Sheep Drug Metab. Dispos., August 1, 2007; 35(8): 1285 - 1291. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kumar, H. Wong, S. A. Yeung, K. W. Riggs, F. S. Abbott, and D. W. Rurak Disposition of Valproic Acid in Maternal, Fetal, and Newborn Sheep I: Placental Transfer, Plasma Protein Binding, and Clearance Drug Metab. Dispos., July 1, 2000; 28(7): 845 - 856. [Abstract] [Full Text] |
||||